A review of the uses and limitations of tocainide—a class IB antiarrhythmic agent
- 31 October 1985
- journal article
- clinical trial
- Published by Elsevier in American Heart Journal
- Vol. 110 (4) , 856-863
- https://doi.org/10.1016/0002-8703(85)90470-3
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Aggravation and provocation of ventricular arrhythmias by antiarrhythmic drugs.Circulation, 1982
- Open clinical studies at a referral center: Chronic maintenance tocainide therapy in patients with recurrent sustained ventricular tachycardia refractory to conventional antiarrhythmic agentsAmerican Heart Journal, 1980
- A prospective randomized trial of tocainide in patients following myocardial infarctionAmerican Heart Journal, 1980
- Prophylaxis of ventricular tachyarrhythmias with intravenous and oral tocainide in patients with and recovering from acute myocardial infarctionAmerican Heart Journal, 1980
- Hemodynamic and antiarrhythmic effects of tocainide in patients with acute myocardial infarctionAmerican Heart Journal, 1980
- Tocainide for refractory ventricular arrhythmias of myocardial infarctionAmerican Heart Journal, 1980
- Tocainide therapy for refractory ventricular arrhythmiasAmerican Heart Journal, 1980
- Clinical electrophysiologic effects of tocainide.Circulation, 1978
- Suppression of ventricular ectopic depolarizations by tocainide.Circulation, 1977
- Clinical efficacy and pharmacokinetics of a new orally effective antiarrhythmic, tocainide.Circulation, 1976